Search Results - "Bijen, Helena M."

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
  2. 2

    Preclinical Strategies to Identify Off-Target Toxicity of High-Affinity TCRs by Bijen, Helena M., van der Steen, Dirk M., Hagedoorn, Renate S., Wouters, Anne K., Wooldridge, Linda, Falkenburg, J.H. Frederik, Heemskerk, Mirjam H.M.

    Published in Molecular therapy (02-05-2018)
    “…Adoptive transfer of T cells engineered with a cancer-specific T cell receptor (TCR) has demonstrated clinical benefit. However, the risk for off-target…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Mutated NPM1 As Target for Immunotherapy of Acute Myeloid Leukemia by Van Der Lee, Dyantha I., Bijen, Helena M., Hagedoorn, Renate S., Honders, Willy M., Kester, Michel G.D., van der Steen, Dirk M., de Ru, Arnoud H., Jedema, Inge, Veelken, Hendrik, Heemskerk, Mirjam H.M., van Veelen, Peter A., Falkenburg, J.H. Frederik, Griffioen, Marieke

    Published in Blood (08-12-2017)
    “…In AML, nucleophosmin (NPM1) is the gene that is most frequently mutated. Mutated NPM1 (ΔNPM1) is a driver gene that is essential for malignant transformation…”
    Get full text
    Journal Article